AVE 33.3% 0.2¢ avecho biotechnology limited

Dougal the strategy of appointing a CEO before the board was...

  1. 1,053 Posts.
    lightbulb Created with Sketch. 4
    Dougal the strategy of appointing a CEO before the board was flawed and a number of large shareholders let Harry know this. It is the board that appoints the ceo and even at that time the current board knew they would be required to stand down as new credentialed candidates where signed up. Not only would any CEO appointed then be very nervous that all their supporters had just fallen on their sword a couple of months after they started but obviously with a more pharma focused board we should be able to attract higher quality candidates. So you are correct that the strategy presented 6mths ago in his respect wasn't followed but purely because the current strategy made far more sense. The board and Harry listened to shareholder advice and decided that there was logic in the argument.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $11.50K 4.335M

Buyers (Bids)

No. Vol. Price($)
63 101422109 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 20872825 7
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.